If 1y post PCI or CAD w o coronary revasc OAC monotherapy preferred over combo tx w aspirin P2Y12 inhibitors

By rray, 26 January, 2024
Detail (Long)
If ≥1y post PCI or CAD w/o coronary revasc, OAC monotherapy preferred over combo tx w/ aspirin/P2Y12 inhibitors.